Trial intelligence / Profile preview

Efficacy and Safety of Lovaza with Atorvastatin in Hypertriglyceridemia

NCT00435045Phase 3Completed

Sponsor
GSK
Start
Feb 2007
Primary completion
Oct 2007
Modality
Small Molecules
01

Overview

A Phase 3 trial of eicosapentaenoic acid + docosahexaenoic acid in hypertriglyceridemia, sponsored by GSK. Started Feb 2007; status: completed.

02

Drugs

eicosapentaenoic acid + docosahexaenoic acid
03

Conditions

hypertriglyceridemia

Beyond the preview

Go deeper on NCT00435045.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00435045.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call